Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort

Bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) is a recommended once-daily single tablet regimen for the treatment of people living with HIV-1 (PLWH). We aimed to assess efficacy, safety and tolerability of BIC/FTC/TAF among PLWH, with a specific focus on people older than 55...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzaro, Alessandro, Cacciola, Elio Gentilini, Borrazzo, Cristian, Innocenti, Giuseppe Pietro, Cavallari, Eugenio Nelson, Mezzaroma, Ivano, Falciano, Mario, Fimiani, Caterina, Mastroianni, Claudio Maria, Ceccarelli, Giancarlo, d’Ettorre, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774414/
https://www.ncbi.nlm.nih.gov/pubmed/35054243
http://dx.doi.org/10.3390/diagnostics12010076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774414/
https://www.ncbi.nlm.nih.gov/pubmed/35054243
http://dx.doi.org/10.3390/diagnostics12010076

Ejemplares similares